Fluorescence-Guided Optimization of Sarcoma Margins
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Aarhus
About this trial
This is a Danish national multicenter prospective cohort study to evaluate if fluorescence-guided surgery (FGS) using indocyanine green (ICG) can reduce the rate of positive margins following sarcoma resection.
Eligibility criteria
Qualifiers
Biopsy verified intermediate-to-high grade sarcoma of theextremity or trunk wall
Age>18 years old
Tumor operable
Curative intent at time of surgery
Disqualifiers
History of allergic reaction to iodine-containing pharmaceuticals
End-stage renal disease or eGFR <15
Patient decision
Lack of capacity
Trial design
Treatments tested in this trial
- Fluorescent-guided Surgery
Treatment groups
90 Participants
are divided into 1 treatment groupLocations
2Aarhus University Hospital8200, Aarhus N Denmark
Rigshospitalet2100, Copenhagen Denmark
Sponsors and collaborators
University of Aarhus
Lead sponsor
Source ClinicalTrials.gov